Amundi Boosts Holdings in HCA Healthcare, Inc. $HCA

Amundi raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 36.2% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 394,665 shares of the company’s stock after purchasing an additional 104,817 shares during the quarter. Amundi owned 0.17% of HCA Healthcare worth $149,199,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the company. Saudi Central Bank purchased a new stake in HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter worth about $27,000. Ameriflex Group Inc. purchased a new position in HCA Healthcare in the 2nd quarter worth about $27,000. Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $27,000. Finally, Clearstead Trust LLC lifted its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on HCA shares. Jefferies Financial Group increased their price target on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Mizuho raised their target price on HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Barclays raised their price objective on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Zacks Research downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Finally, TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $486.40 on Monday. The stock has a fifty day simple moving average of $459.97 and a two-hundred day simple moving average of $410.43. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00. The firm has a market capitalization of $110.99 billion, a PE ratio of 18.80, a PEG ratio of 1.44 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter last year, the business posted $4.90 earnings per share. The firm’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.